Cargando…
Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease afflicting about one third of the world’s population and 30 % of the US population. It is induced by consumption of high-lipid diets and is characterized by liver inflammation and subsequent liver pathology. Obesity and...
Autores principales: | Kim, Do-Geun, Krenz, Antje, Toussaint, Leon E., Maurer, Kirk J., Robinson, Sudie-Ann, Yan, Angela, Torres, Luisa, Bynoe, Margaret S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700622/ https://www.ncbi.nlm.nih.gov/pubmed/26728181 http://dx.doi.org/10.1186/s12974-015-0467-5 |
Ejemplares similares
-
Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer’s disease in wild-type, C57BL/6 mice
por: Torres, Luisa, et al.
Publicado: (2018) -
ADS accelerators
por: Seidel, Mike
Publicado: (2013) -
Review of Accelerators for ADS
por: Mueller, Alex C.
Publicado: (2013) -
Report on Workshop: Accelerators for ADS
por: Bellodi, G, et al.
Publicado: (2014) -
Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
por: Cho, Soo Hyun, et al.
Publicado: (2021)